Pune, India -- (SBWIRE) -- 03/16/2018 -- The Global Allergic Rhinitis Market is expected to reach USD 124,896.6 Million by 2023, and the market is projected to grow at a CAGR of ~ 13.3 % during the forecast period 2018-2023.

Allergic Rhinitis Market Regional Analysis:

Geographically, the region of this market is segmented into four major region, they are America, Europe, Asia-Pacific along with Middle East and Africa. The North America is dominating the global allergic rhinitis market. The U.S. has the highest number of hay fever incidences. The second largest market of global allergic rhinitis market is Europe. The Asia Pacific allergic rhinitis market is recently witnessing a high growth due to greater awareness about this disease and its treatment. The rising incidence of allergic rhinitis in this region is because of increasing population. Japan has the highest incidence of allergic rhinitis after US.

Moreover, government support and research and development are adding fuel to the growth of the market. Furthermore, high rate of treatment may hinder the growth of market during forecast period.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1547 .

The Worldwide Allergic Rhinitis Market Segmentation:

The market of allergic rhinitis is segmented into types by treatment and by test. The types of allergic rhinitis include seasonal, perennial and non-allergic rhinitis. On the basis of treatment the market is segmented into antihistamines, decongestants, eye drops, nasal sprays, immunotherapy, sublingual immunotherapy (SLIT) and home remedies.

Moreover, companies are investing more in research and development for introducing better treatment for vision problem. For instance, in 2015, Alcon Laboratories Inc. launched next generation hydrogen peroxide lens care solution, AOSEPT PLUS with HydraGlyde Solution (CLEAR CARE PLUS in North America). Additionally in 2016, Alcon Laboratories Inc. introduced The NGENUITY 3D Visualization System to aid in retinal surgery visualization. Also, company investing more into mergers and acquisition for entering the new market, for instance, in 2016, Johnson & Johnson acquired Abbott's vision care business unit (AMO).

Global Allergic Rhinitis Market Players:

There are various players in the allergic rhinitis market; some of them are Merck (US), GSK (UK), Sanofi (France), Cigna (USA), Himalaya (India), J&J (US), Chong kun Dang Pharmaceutical Corp. (South Korea), Faes, Farma (Spain), Glenmark Pharmaceutical (India), Hisamitsu Pharmaceutical Co.in (Japan), Ampio pharmaceutical Inc. (US), Olain Farm (Lavtvia), and others.

Johnson & Johnson, the company has a wide range of products which also includes medical products. The company recently has announced the launch of allergy spray named Rhinocort that is available over the counter. The Rhinocort will be sold over the counter all over America. The company is also the maker of a very well know product the Zyrtec.

Another big brand that has a huge product variety for the allergic symptoms is The Himalayas Drug Company which is an Indian brand and has herbal products for various diseases. There are various players in US, Japan and China who are operating in the global allergic rhinitis market.

TOC Continued….!

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1547 .

Major TOC of Allergic Rhinitis Market:

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS


Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.